• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Down 0.93%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    1.93 Up 0.15(8.43%) 1:06PM EST - Nasdaq Real Time Price
    Prev Close:1.78
    Open:1.79
    Bid:1.92 x 1300
    Ask:1.93 x 6500
    1y Target Est:13.00
    Beta:2.68404
    Next Earnings Date:23-Feb-16BCRX Earnings announcement
    Day's Range:1.78 - 2.09
    52wk Range:1.76 - 16.83
    Volume:3,425,415
    Avg Vol (3m):879,221
    Market Cap:141.54M
    P/E (ttm):N/A
    EPS (ttm):-0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BCRX

    Comparison

    Symbol% ChgMkt Cap
    BCRXUp 8.43%141.54M
    GSKDown 0.72%94.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.61
    Quarterly EPS Est (Dec-15) :-0.25
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback